Arrive AI Brings Secure Autonomous Delivery Infrastructure to HIMSS 2026

Rhea-AI Summary

Arrive AI (NYSE:ARAI) will showcase the Arrive Point™ Network at HIMSS Global Health Conference & Exhibition on March 10, 2026, at Booth #12122 on the Artificial Intelligence Trail, Venetian Level 1.

The network provides secure, unattended transfer infrastructure to close robotic handoff gaps, enabling hospitals to run continuous autonomous deliveries for medications, lab samples, and supplies.

Key Figures

Registered resale shares: 10,000,000 shares of common stock Nine-month 2025 revenue: $98,175 Nine-month 2025 net loss: $8.9 million +5 more

8 metrics

Registered resale shares 10,000,000 shares of common stock Form S-1 resale registration for Streeterville Capital

Nine-month 2025 revenue $98,175 Revenue for nine months ended September 30, 2025

Nine-month 2025 net loss $8.9 million Net loss for nine months ended September 30, 2025

Operating cash flow negative $5.0 million Operating cash flow for nine months ended September 30, 2025

Q3 2025 revenue $7,450 Quarter ended September 30, 2025

Q3 2025 net loss $2.24 million Quarter ended September 30, 2025

Prepaid financing proceeds $10,000,000 Cash received from Streeterville Capital under unsecured promissory note

Prepaid share capacity up to $40 million Pre-paid share purchase capacity with Streeterville Capital

Market Reality Check

Price: $1.05 Vol: Volume 238,438 (relative ...

normal vol

$1.05 Last Close

Volume Volume 238,438 (relative volume 0.72x) is below the 20-day average of 331,567. normal

Technical Price at $1.055 is trading below the 200-day MA of $4.88, reflecting sustained technical pressure.

Peers on Argus

Peers show mixed strength: within close peers, REKR is up 7.23%, AISP up 3.88%, ...

3 Up

Peers show mixed strength: within close peers, REKR is up 7.23%, AISP up 3.88%, HPAI up 3.29%, while LHSW is down 1.03%. Momentum scanner also flags REKR, ZENA, and LHSW moving up, but the target’s intraday direction is not specified, so alignment with these moves cannot be determined.

Previous AI Reports

5 past events · Latest: Mar 05 (Positive)

Same Type Pattern 5 events

Date	Event	Sentiment	Move	Catalyst
Mar 05	Hospital deployment paper	Positive	+0.0%	White paper on live hospital biospecimen automation using Arrive Points and a robot.
Feb 16	Global AI expansion	Positive	+1.7%	Showcase of global autonomous logistics expansion and multimodal collaborations in India.
Feb 09	Autonomous delivery demo	Positive	+6.4%	End-to-end ground robot and drone delivery demo to an Arrive Point with 5G.
Jan 26	Strategic playbook	Positive	-7.3%	CEO outlined AI-first Plai Book framework and IP-heavy growth strategy.
Jan 22	Commercial leader hire	Positive	+4.7%	Appointment of Head of Commercialization to drive go-to-market and enterprise deals.

Pattern Detected

Recent AI-related news often produced modest positive moves, but reactions have been inconsistent, including one notable selloff on otherwise constructive strategic commentary.

Recent Company History

Over recent months, Arrive AI has repeatedly highlighted its AI-driven logistics platform across hospitals and innovation showcases. Prior AI-tagged news covered a live hospital deployment white paper on Mar 05, 2026, global expansion and collaborations on Feb 16, 2026, and a multi-modal robot-and-drone demo on Feb 09, 2026. Strategic culture and IP focus were outlined on Jan 26, 2026, and go-to-market leadership was added on Jan 22, 2026. Today’s HIMSS presence continues this theme of healthcare-focused autonomous delivery infrastructure.

Historical Comparison

+1.1% avg move · Past AI-tagged announcements for ARAI moved the stock an average of 1.09%. The current 2.91% pre-new...

AI

+1.1%

Average Historical Move AI

Past AI-tagged announcements for ARAI moved the stock an average of 1.09%. The current 2.91% pre-news gain sits modestly above that typical reaction range.

AI-tagged news shows a progression from leadership hires and strategic frameworks to live demos, global deployments, and detailed hospital use cases, with the current HIMSS event reinforcing the healthcare logistics focus.

Market Pulse Summary

This announcement reinforces Arrive AI’s focus on hospital logistics, positioning the Arrive Point™ ...

Analysis

This announcement reinforces Arrive AI’s focus on hospital logistics, positioning the Arrive Point™ Network as infrastructure for secure, unattended handoffs between robots, staff, and potentially drones. Prior AI-tagged events detailed live hospital deployments, multi-modal demos, and commercialization leadership, while SEC filings show early-stage revenue of $98,175 against a nine-month net loss of $8.9 million. Investors may watch for concrete hospital contracts and utilization metrics to complement these showcase events.

Key Terms

autonomous robots, chain-of-custody, autonomous vehicles

3 terms

autonomous robots technical

"Hospitals across the country are deploying autonomous robots to move medications..."

Autonomous robots are machines that can sense their surroundings, make decisions, and carry out tasks without constant human control—think of a self-driving vehicle or a warehouse worker that navigates and operates on its own. For investors, they matter because they can cut labor costs, boost output and precision, and create new revenue streams, but they also carry risks around upfront investment, regulatory approval, maintenance, and potential liability that can affect a company’s profitability and valuation.

chain-of-custody regulatory

"Sensitive materials like lab samples, medications, and critical supplies require verified chain-of-custody transfers."

A chain-of-custody is the documented trail showing who handled, transferred, stored and accessed an asset, sample or record from origin to its final destination. Think of it like a series of signed receipts that prove an item was tracked and not tampered with. Investors care because a clear chain-of-custody preserves evidence, regulatory compliance and product integrity, reducing legal, valuation and operational risks that can affect company value.

autonomous vehicles technical

"For healthcare leaders already exploring robotics, autonomous vehicles, or AI-enabled logistics..."

Vehicles that use on-board sensors, cameras and software to navigate and drive without a human actively controlling them; think of them as robotic chauffeurs that can perceive roads, make decisions and follow traffic rules. For investors, they matter because they can reshape transportation costs, create new revenue streams (rides, logistics, software) and change regulatory and liability risks, so their adoption affects manufacturers, tech suppliers, insurers and transportation demand.

AI-generated analysis. Not financial advice.

"Have Robots? You're Only Halfway There."

LAS VEGAS, NV / ACCESS Newswire / March 10, 2026 / Arrive AI, a leader in autonomous delivery infrastructure, will showcase the Arrive Point™ Network at the HIMSS Global Health Conference & Exhibition this week, inviting healthcare innovators to rethink what it truly takes to achieve autonomous logistics inside hospitals and healthcare systems.

Visitors can find Arrive AI at Booth #12122 on the Artificial Intelligence Trail, Venetian Level 1, where the company will highlight how healthcare organizations already investing in robotics can unlock the full potential of automation.

The message is simple:

Have Robots? You're only halfway there.

Hospitals across the country are deploying autonomous robots to move medications, lab samples, and medical supplies. But many health systems quickly discover a critical gap in the automation chain.

Robots can move items.
But handoffs break automation.

Without secure transfer infrastructure, robots still rely on people to receive, verify, and manage deliveries - introducing delays, risk, and labor costs back into the process.

The Arrive Point™ Network solves the handoff, creating a secure, unattended transfer system that enables hospitals to operate a true autonomous delivery network.

"The key to scaling autonomy isn't just the robot," said Dan O'Toole, Founder and CEO of Arrive AI. "It's mastering the moment of transfer. That's where risk, delay, and liability concentrate. Our infrastructure ensures deliveries are secure, verified, and accessible exactly when they're needed."

Healthcare logistics often involves time-sensitive and irreplaceable materials, including lab specimens, medications, and surgical supplies. When delivery depends on perfect timing between humans and machines, systems break down.

Autonomy needs infrastructure. Arrive AI provides it.

The Arrive Point™ Network is designed to enable:

Speed
Continuous autonomous transport eliminates waiting, batching, and manual handoffs.

Savings
Nurses and medical assistants spend valuable time walking materials across campus instead of caring for patients.

Security
Sensitive materials like lab samples, medications, and critical supplies require verified chain-of-custody transfers.

Unattended Operation
Hospitals experimenting with robotics often still rely on people for deliveries. The Arrive Point™ enables secure, unattended transfer between people, robots, and drones.

For healthcare leaders already exploring robotics, autonomous vehicles, or AI-enabled logistics, Arrive AI offers the missing infrastructure layer that makes hospital-scale autonomy possible.

Visit Arrive AI at HIMSS

Venetian Level 1
The Artificial Intelligence Trail
Booth #12122

Conference attendees are invited to stop by the booth to learn how the Arrive Point™ Network can transform hospital logistics into a fully autonomous, secure delivery ecosystem.

About Arrive AI

Arrive AI (NASDAQ:ARAI) is an autonomous delivery infrastructure company specializing in patented AI-powered smart receptacles called Arrive Points™. These secure, climate-assisted smart mailboxes enable fully asynchronous handoffs between robots, drones, couriers, and end users. Arrive AI's Autonomous Last Mile (ALM) platform provides tracking, smart logistics alerts, and advanced chain-of-custody controls, forming the backbone of next-generation autonomous delivery networks. Learn more at www.arriveai.com.

Media Contact:
Kylie Conway
media@arriveai.com

Investor Relations Contact:
Alliance Advisors IR
ARAI.IR@allianceadvisors.com

Cautionary Note Regarding Forward Looking Statements


This news release and statements of Arrive AI's management in connection with this news release or related events contain or may contain "forward-looking statements" within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. In this context, forward-looking statements mean statements, including but not limited to, statements related to future events, which may impact our expected future business and financial performance, and often contain words such as "expects", "anticipates", "intends", "plans", "believes", "potential", "will", "should", "could", "would", "optimistic" or "may" and other words of similar meaning. These forward-looking statements are based on information available to us as of the date of this news release and represent management's current views and assumptions. Forward-looking statements are not guarantees of future performance, events or results and involve significant known and unknown risks, uncertainties and other factors which may be beyond our control. Readers are cautioned not to place undue reliance on these forward-looking statements, which apply only as of the date of this news release. Potential investors should review Arrive AI's filings with the United States Securities and Exchange Commission for more complete information, including the risk factors that may affect future results, which are available for review at www.sec.gov (http://www.sec.gov/). Accordingly, forward-looking statements should not be relied upon as a predictor of actual results. We do not undertake to update our forward-looking statements to reflect events or circumstances that may arise after the date of this news release, except as required by law.

SOURCE: Arrive AI Inc.

View the original press release on ACCESS Newswire

FAQ

What is Arrive AI presenting at HIMSS 2026 (ARAI)?

Arrive AI is presenting the Arrive Point™ Network, a secure handoff infrastructure for autonomous deliveries. According to the company, the system enables unattended, verified transfers between robots, people, and drones to reduce delays and manual handoffs in hospitals.

How does the Arrive Point™ Network improve hospital logistics for ARAI?

It creates secure, unattended transfer points that eliminate manual handoffs and waiting. According to the company, this infrastructure aims to speed deliveries, improve chain-of-custody for sensitive items, and free clinical staff from campus transport tasks.

Where and when can investors see Arrive AI (ARAI) demo the technology at HIMSS 2026?

Arrive AI will demo at Booth #12122 on the Artificial Intelligence Trail, Venetian Level 1 during HIMSS 2026. According to the company, attendees can visit the booth to see how the Arrive Point™ enables continuous autonomous transport in hospitals.

What problems does the Arrive Point™ Network solve for hospitals adopting robotics (ARAI)?

The network solves broken handoffs that reintroduce delays, risk, and labor costs into automated deliveries. According to the company, verified unattended transfers reduce reliance on staff to receive and manage deliveries, improving timeliness and security.

Will the Arrive Point™ Network support drones and autonomous vehicles for ARAI deployments?

Yes — the system is designed for transfers between people, robots, and drones to enable end-to-end autonomy. According to the company, the Arrive Point™ enables secure, verified handoffs across multiple delivery modalities within hospital environments.